Shibin Zhou

Medicine & Life Sciences

1. Neoplasms 100%
2. Clostridium 79%
3. Spores 54%
4. Mutation 43%
5. Liposomes 34%
6. Peptides 33%
7. Bispecific Antibodies 32%
8. Bacteria 28%
9. Genes 26%
10. Immunotherapy 26%
11. T-Cell Antigen Receptor 25%
12. T-Lymphocytes 23%
13. Colorectal Neoplasms 23%
14. Transforming Growth Factors 23%
15. Coronavirus 23%
16. Turcot syndrome 21%
17. Anaerobic Bacteria 21%
18. Therapeutics 20%
19. Synapses 20%
20. Proteins 20%
21. Activins 19%
22. DNA Mismatch Repair 19%
23. Germination 19%
24. Pharmaceutical Preparations 18%
25. Bacterial Infections 18%
26. fialuridine 17%
27. HLA Antigens 17%
28. Antibodies 16%
29. Dextrans 16%
30. Storm Syndrome 15%
31. Clone Cells 15%
32. SARS Virus 15%
33. clathrin assembly protein AP180 14%
34. 5-iodouracil 14%
35. Chimeric Antigen Receptors 14%
36. Major Histocompatibility Complex 13%
37. Adrenergic Antagonists 13%
38. Growth 13%
39. Nanoparticles 13%
40. Adrenergic alpha-1 Receptor Antagonists 12%
41. Thymidine Kinase 12%
42. Genome 12%
43. Names 12%
44. Blood Vessels 12%
45. Theranostic Nanomedicine 11%
46. Cytokine Release Syndrome 11%
47. Lung Neoplasms 11%
48. Antineoplastic Agents 11%
49. Vesicular Transport Adaptor Proteins 11%
50. Cell Line 11%